Tag Archives: ENLK

Best Medical Stocks To Watch Right Now

ReWalk Robotics (NASDAQ: RWLK) and Invacare (NYSE:IVC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, valuation, profitability, analyst recommendations, earnings and dividends.

Risk & Volatility

Get ReWalk Robotics alerts:

ReWalk Robotics has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Comparatively, Invacare has a beta of 2.52, indicating that its share price is 152% more volatile than the S&P 500.

Dividends

Invacare pays an annual dividend of $0.05 per share and has a dividend yield of 0.3%. ReWalk Robotics does not pay a dividend. Invacare pays out -2.6% of its earnings in the form of a dividend.

Valuation & Earnings

This table compares ReWalk Robotics and Invacare’s top-line revenue, earnings per share (EPS) and valuation.

Best Medical Stocks To Watch Right Now: Energy Transfer Equity, L.P.(ETE)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Management teams tend to be very coy about what they’re working on behind closed doors. Energy Transfer Equity’s (NYSE:ETE) leadership, on the other hand, was very transparent about what’s going on behind the scenes during the company’s first-quarter conference call. They openly answered analysts’ questions, which provided investors with an interesting glimpse into what’s ahead.

  • [By Matthew DiLallo]

    Like last quarter, Energy Transfer Partners delivered strong earnings and cash flow growth. Because of that, the company was able to cover its jaw-dropping 12.4%-yielding distribution by a healthy 1.15 times. That slight decline from the year-ago quarter was caused by parent companyEnergy Transfer Equity (NYSE:ETE)significantly reducing its support. For a better comparison, the coverage ratio would have still been a solid 1.1 in this year’s first quarter without any assistance from Energy Transfer Equity, while it would have been a worrisome 0.98 in the year-ago period without the parent company’s help. That improvement isexactly what investors wanted to see this quarter.

  • [By Stephan Byrd]

    D.A. Davidson & CO. reduced its stake in Energy Transfer Equity (NYSE:ETE) by 10.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 46,328 shares of the pipeline company’s stock after selling 5,550 shares during the period. D.A. Davidson & CO.’s holdings in Energy Transfer Equity were worth $658,000 at the end of the most recent quarter.

  • [By Matthew DiLallo]

    One reason investors are worried that Energy Transfer might need to reduce its distribution is that the company barely generates enough cash flow to support it without the help of its parent Energy Transfer Equity (NYSE:ETE). In 2017, Energy Transfer Partners produced $4.19 billion in distributable cash flow and would have paid out $4.15 billion to investors if it wasn’t for the fact that Energy Transfer Equity relinquished its rights to $656 million of that cash. While that support boosted the distribution coverage ratio from a tight 1.0 times to a more comfortable 1.2 times, it was only a temporary fix since Energy Transfer Equity’s support will diminish significantly in 2018 before declining further in 2019 and 2020.

Best Medical Stocks To Watch Right Now: EnLink Midstream Partners, LP(ENLK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on EnLink Midstream Partners (ENLK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    ValuEngine upgraded shares of EnLink Midstream Partners (NYSE:ENLK) from a strong sell rating to a sell rating in a research report released on Thursday morning.

Best Medical Stocks To Watch Right Now: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Best Medical Stocks To Watch Right Now: NIC Inc.(EGOV)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub upgraded shares of NIC (NASDAQ:EGOV) from a buy rating to a strong-buy rating in a research note published on Friday morning.

    Several other research firms also recently commented on EGOV. Zacks Investment Research downgraded NIC from a hold rating to a sell rating in a report on Monday, January 8th. ValuEngine downgraded NIC from a sell rating to a strong sell rating in a report on Wednesday, May 2nd. Barrington Research restated a hold rating on shares of NIC in a report on Monday, April 30th. TheStreet downgraded NIC from a b- rating to a c rating in a report on Thursday, March 8th. Finally, Loop Capital decreased their price objective on NIC to $14.00 and set a hold rating for the company in a report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, five have issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $18.33.

Best Medical Stocks To Watch Right Now: Nielsen N.V.(NLSN)

Advisors’ Opinion:

  • [By Keith Noonan, Rich Smith, and Timothy Green]

    With that in mind, we asked three Motley Fool investors to profile an income-generating stock that’s currently flying under the radar but has some truly amazing qualities. Read on to see why they thinkNielsen Holdings (NYSE:NLSN), Vail Resorts (NYSE:MTN), and The Walt Disney Company (NYSE:DIS)are top dividend stocks that aren’t getting their due.

  • [By Joseph Griffin]

    These are some of the news articles that may have effected Accern’s scoring:

    Get GGP alerts:

    Read This Before Trade: Facebook, Inc. (FB), GGP Inc. (GGP) (nmsunews.com) Ggp Inc (GGP)’s Weekly Performance of -0.90% Is Nothing to Write Home About (parkcitycaller.com) Is GGP Inc (NYSE:GGP) A Good Dividend Stock? (finance.yahoo.com) GGP (GGP) Downgraded by Zacks Investment Research to “Hold” (americanbankingnews.com) Dazzling Stocks: GGP Inc. (NYSE:GGP), Nielsen Holdings plc (NYSE:NLSN), AmerisourceBergen Corporation (NYSE … (thestreetpoint.com)

    GGP has been the subject of a number of recent research reports. Royal Bank of Canada restated a “buy” rating and set a $24.00 target price on shares of GGP in a research report on Monday, February 12th. Boenning Scattergood reissued a “buy” rating and issued a $35.00 target price on shares of GGP in a research note on Tuesday, March 27th. Mizuho raised GGP from a “neutral” rating to a “buy” rating and set a $24.00 target price for the company in a research note on Monday, March 19th. Zacks Investment Research upgraded GGP from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a report on Wednesday, April 11th. Finally, Barclays cut their price target on GGP from $24.00 to $23.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 30th. Three analysts have rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company’s stock. GGP currently has an average rating of “Hold” and a consensus price target of $24.92.

  • [By Joseph Griffin]

    ARP Americas LP grew its position in Nielsen Holdings (NYSE:NLSN) by 41.2% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 14,400 shares of the business services provider’s stock after buying an additional 4,200 shares during the period. ARP Americas LP’s holdings in Nielsen were worth $458,000 as of its most recent SEC filing.

Best Medical Stocks To Watch Right Now: Rocky Mountain Chocolate Factory Inc.(RMCF)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.

  • [By Max Byerly]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Best Biotech Stocks For 2019

Investment company Wechter Feldman Wealth Management, Inc. buys SPDR Select Sector Fund – Utilities, Vanguard Total Stock Market, SPDR Series Trust S&P Biotech, Berkshire Hathaway Inc, Vanguard Total Bond Market, sells iShares Core S&P Mid-Cap, iShares Russell Mid-cap Value, Vanguard High Dividend Yield ETF – DNQ, iShares Russell 1000 Value, Vanguard Mid-Cap ETF – DNQ during the 3-months ended 2017-06-30, according to the most recent filings of the investment company, Wechter Feldman Wealth Management, Inc.. As of 2017-06-30, Wechter Feldman Wealth Management, Inc. owns 27 stocks with a total value of $124 million. These are the details of the buys and sells.

New Purchases: XLU, XBI, BRK.B, Added Positions: VTI, IWV, TIP, AGG, IWB, OEF, IVV, VIG, BND, JNJ, Reduced Positions: T, XOM, GE, Sold Out: IJH, IWS, VYM, IWD, VO, VTV, VB, IJR,

For the details of Wechter Feldman Wealth Management, Inc.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Wechter+Feldman+Wealth+Management%2C+Inc.

Best Biotech Stocks For 2019: 2U, Inc.(TWOU)

Advisors’ Opinion:

  • [By David Kretzmann]

    Since its IPO in March 2014, 2U (NASDAQ:TWOU) stock is up over 160% as the company forges partnerships with famous schools, including Georgetown, Yale, Berkeley, and New York University.

Best Biotech Stocks For 2019: EnLink Midstream Partners, LP(ENLK)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    EnLink Midstream Partners (ENLK) is sponsored by independent oil and gas exploration giant Devon Energy (DVN), the owner of this acreage.

    These basins offer superior economics and EnLink’s close relationship with Devon provides leveraged exposure to the upstream operator’s accelerating activity in these plays.

Best Biotech Stocks For 2019: Allstate Corporation (The)(ALL)

Advisors’ Opinion:

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    Read on to see why they pickedAllstate(NYSE:ALL),EPAM Systems(NYSE:EPAM), andUniversal Display(NASDAQ:OLED).

    Image source: Getty Images.

  • [By Michael Flannelly]

    Wells Fargo analysts see a number of upside catalysts for The Allstate Corporation (ALL), plus a positive trend for automobile insurers as a whole. As such, the analysts upgraded the insurance provider on Thursday.

    The analysts upgraded ALL from “Market Perform” to “Outperform” and boosted its valuation range from $48-$52 to $58-$62. This new valuation range suggests a 16% to 24% upside to the stock’s Wednesday closing price of $50.11.

    “We are upgrading the shares of Allstate to Outperform from Market Perform on the basis of several fundamental reasons unique to the company as well as several positive, emerging structural trends for auto insurers in general,” Wells Fargo analyst John Hall stated. “We do not believe that the market has yet paid for potential unit growth within Allstate’s branded standard book of auto insurance, something we envision occurring over the next 6-12 months.”

    As for some of the positive personal auto insurance sector trends, Hall noted, “These would include shifting demographics toward a safer driving population mix (more old drivers and fewer young drivers), changing driving habits particularly among millennials, a safer U.S. personal auto fleet, rising car sales pointing to positive symbol shift as well as industry conditions encouraging market share consolidation.”

    Wells Fargo boosted Allstate’s 2013 EPS estimates from $4.62 to $4.85 and 2014 EPS estimates from $4.85 to $5.20.

    Allstate shares were mostly flat during pre-market trading on Thursday. The stock is up 24.74% year-to-date.

  • [By Shauna O’Brien]

    Credit Suisse reported on Thursday that it has raised its estimates on insurance company The Allstate Corporation (ALL).

    The firm has raised its price target on ALL to $62. This price target suggests a 16% upside from the stock’s current price of $52.23. Analysts currently have an “Outperform” rating on ALL.

    Credit Suisse has also boosted estimates on ALL as its management is increasing returns.

    Allstate shares were up 32 cents, or 0.62%, during Thursday morning trading. The stock is up 30% YTD.

Top Blue Chip Stocks To Invest In Right Now

Over the past year, the performance of T. Rowe Price Blue Chip Growth (TRBCX has underscored why it pays to sit tight when a fund with a superior long-term record hits a speed bump. In 2016, as investors turned away from shares of the fast-growing, large-capitalization stocks that Blue Chip targets in favor of more-undervalued fare, the fund lagged the stock market dramatically. Stocks that had previously buoyed the fund, such as Amazon.com and Facebook, were suddenly a drag, says manager Larry Puglia. And energy and utility stockssectors that Blue Chip tends to ignoreperformed exceptionally well.

See Also: Kip 25 Best No-Load Mutual Funds 2017

But these kinds of style shifts dont last forever. Large-cap growth stocks, led by the technology sector, are rebounding this year, and Blue Chip is benefiting. In the first three months of 2017, the fund returned 10.4%, beating Standard & Poors 500-stock index by 4.3 percentage points. Over the past 12 months, Blue Chip, a member of the Kiplinger 25, outpaced the index by nearly a full percentage point. (Prices and returns are through March 31)

Top Blue Chip Stocks To Invest In Right Now: Cerner Corporation(CERN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Cerner (CERN) soared to the top of the S&P 500 today after thehealth care information technology company reported better-than-expected earnings and revenue.

    Getty Images

    Cernergained 7.8% to $64.75 at 5:03 p.m. today, while the S&P 500 declined 0.2% to 2,384.20.

    Canaccord Genuity’s Richard Close and Brian Hoffman contend Cerner may be “rediscovered its mojo.” They explain:

    We reiterate our BUY rating and raise our PT to $66 (was $59) as the company finally
    appears to have provided quarterly and annual targets that it can meet. Possibly more important, analyst expectations sit near the mid-point of guidance, portending upside potential. The outlook appears solid as the company (1) rebuilds a track record of delivering on expectations, (2) reaffirmed confidence in 2017 bookings growth, and (3) has a strengthened pipeline for ITWorks and revenue cycle. CERN may have rediscovered its mojo.

    Cerner’s market capitalization rose to $21.4 billion today from $19.8 billion yesterday.

  • [By ]

    Cerner Corp (Nasdaq: CERN) is the largest pure-play health care IT (HCIT) company in the world with clients in 30 countries and a footprint at 70 of the top 100 global health systems by patient revenue. The company is the market leader in health systems outside the United States with 28% of an otherwise fragmented market.

  • [By Ben Levisohn]

    Cerner (CERN) tumbled to the bottom of the S&P 500 today after meetings earnings forecasts but offering below-consensus guidance.

    Agence France-Presse/Getty Images

    Cerner dropped 4.4% to $51.50 today, while the S&P 500 rose 0.4% to 2,316.10.

    SunTrust Robinson Humphrey’s Sandy Draper and team contend that “most of the bad news is already priced in.” They explain:

    Although we expect this news to weigh on the stock…we think the market has remained cautious on CERN shares heading into the 4Q16 print given the uneven execution throughout 2016 and the post-election regulatory uncertainty that has broadly weighed on the HCIT space as a whole. We observe that CERN shares closed about 3% below the level they traded at this time last year, while the S&P was up over 21% in that time. The muted 12-month performance in the stock suggests the market rightly anticipated unattractive year-end results and 2017 guidance, which suggests to us that downside to CERN shares should be limited.

    Cerner’s market capitalization fell to $17.5 billion today from $18.3 billion yesterday.

    Barron’s Vito Racanelli recommended shares of Cerner on March 16, 2016, when the stock traded at $51.46.

Top Blue Chip Stocks To Invest In Right Now: DepoMed Inc.(DEPO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Depomed Inc (NASDAQ: DEPO) got a boost, shooting up 13 percent to $23.90. Depomed is preparing to put itself up for sale, following calls from activist investor Starboard Value LP to explore such a move, just a year after it fought off a hostile acquisition bid, people familiar with the matter told Reuters.

Top Blue Chip Stocks To Invest In Right Now: EnLink Midstream Partners, LP(ENLK)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    EnLink Midstream Partners (ENLK) is sponsored by independent oil and gas exploration giant Devon Energy (DVN), the owner of this acreage.

    These basins offer superior economics and EnLink’s close relationship with Devon provides leveraged exposure to the upstream operator’s accelerating activity in these plays.

Top Blue Chip Stocks To Invest In Right Now: Frontline Ltd.(FRO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Wednesday afternoon, the energy shares surged 1.23 percent. Meanwhile, top gainers in the sector included Frontline Ltd. (NYSE: FRO), up 5 percent, and JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO), up 6 percent.

  • [By Rich Smith]

    So what is it that’s supporting DHT’s stock price in the face of sliding shipping rates for crude oil, retreating revenue, and plunging profits? Well, for one thing, rival tanker companyFrontline (NYSE:FRO) made an unsolicited bid to acquire DHT last week, offering to pay $475 million for the company. (DHT is currently valued at $460 million.)

  • [By Shanthi Rexaline]

    Frontline Ltd. (NYSE: FRO) is projected to post a loss in the second quarter, translating to a zero dividend, Credit Suisse said in a Tuesday note. Notwithstanding the negative opinion, the shares of the company were up in reaction to the possibility of a deal being struck.

Top Blue Chip Stocks To Invest In Right Now: Protective Life Corporation(PL)

Advisors’ Opinion:

  • [By David Sterman]

    My favorite insurers: AIG (NYSE: AIG) (which I discussed a few months ago), Protective Life (NYSE: PL) and Reinsurance Group of America (NYSE: RGA).

stock market indicators

According to NVIDIA(NASDAQ:NVDA) CEO Jen-Hsun Huang, there are about 1 billion PCs around the world that aren’t “game-ready.” A PC that is not game-ready usually has an older graphics processing unit (GPU) or an integrated GPU. An integrated GPU is a central processing unit (CPU) that has its own built-in graphics capability, and these are less powerful than a stand-alone GPU.

NVIDIA has recently tried to bring these non-game-ready PC owners in to the gaming fold with its PC revival kit. These kits provided everything needed to upgrade an out-of-date PC to power the latest games.

The PC revival kit and NVIDIA’s game streaming service, GeForce NOW, target the millions of potential PC gamers who play infrequently, or haven’t played PC games at all. In order to get the most out of new blockbuster games, a PC needs to be equipped with a powerful GPU, such as NVIDIA’s GeForce GTX 1060 or GTX 1080.

stock market indicators: Chiasma, Inc.(CHMA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Chiasma Inc (NASDAQ: CHMA) was down, falling around 13 percent to $9.51 ahead of the U.S. Food and Drug Administration’s decision on Friday to approve or reject the company’s therapy. The status of its oral treatment for acromegaly, a capsule known as Mycapssa, will be in focus on Friday. The Street’s biotechnology expert Adam Feuerstein stated that an investor source believes the FDA will reject Chiasma’s capsules because data from a single-arm study failed to demonstrate a clinically meaningful benefit among patients.

stock market indicators: Two Harbors Investments Corp(TWO)

Advisors’ Opinion:

  • [By David Hanson]

    This week at the Barclays Capital Global Financials Conference, droves of CEOs, CFOs, and CIOs trotted on stage to address a room full of eager analysts. One of the lone mREITs represented was Two Harbors (NYSE: TWO  ) . CEO Tom Siering and CIO Bill Roth weighed in on the current environment.

stock market indicators: Flowers Foods, Inc.(FLO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Dr Pepper Snapple Group Inc. (NYSE: DPS) to report quarterly earnings at $1.06 per share on revenue of $1.57 billion before the opening bell. Dr Pepper Snapple shares fell 0.07 percent to close at $93.49 on Monday.
    Analysts expect American International Group Inc (NYSE: AIG) to post quarterly earnings at $1.01 per share on revenue of $12.87 billion after the closing bell. AIG shares gained 0.38 percent to $66.39 in after-hours trading.
    Flowers Foods, Inc. (NYSE: FLO) reported in-line earnings for its fourth quarter, while sales missed expectations. Flowers Foods shares fell 1.87 percent to $20.45 in the after-hours trading session.
    Before the markets open, Diebold Nixdorf Inc (NYSE: DBD) is projected to report its quarterly earnings at $0.32 per share on revenue of $1.31 billion. Diebold Nixdorf shares slipped 0.73 percent to close at $27.20 on Monday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Dan Caplinger]

    Consumers across the nation know Flowers Foods (NYSE:FLO) from its Wonder bread, Tastykake snack cakes, and Nature’s Own bakery brands. Yet the truly novel thing about Flowers is how it has done such a good job of building up a national presence in an industry that is typically dominated by local competition. Coming into Monday’s fourth-quarter financial report, Flowers investors were hoping to see at least some growth in sales and earnings, but the bakery company wasn’t able to deliver the pace of expansion that most shareholders really want to see.

stock market indicators: Tucows Inc.(TCX)

Advisors’ Opinion:

  • [By Anders Bylund]

    Shares of Tucows (NASDAQ:TCX) rose 12.1% in March 2017, according to data from S&P Global Market Intelligence.

    So what

    The provider of online business services and a budding bundle of mobile and fiber-optic communications products started March with a bang, announcing a brand-new $40 million share buyback program. For a company with a $476 million market cap at the time, that’s a pretty serious and shareholder-friendly commitment.

  • [By Lisa Levin]

    Tucows Inc. (USA) (NASDAQ: TCX) shares shot up 17 percent to $42.45 after the company announced plans to acquire eNom from Rightside for $83.5 million.

stock market indicators: Ingles Markets Incorporated(IMKTA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Not all grocers will suffer from Amazon’s growing reach, but those who sell to high-income customers in the top 25 U.S. markets may see their business erode. Among those names include Costco (COST) , Trader Joe’s and Whole Foods (WFM) , which have the most to lose according to Barclays. On the other hand, Walmart (WMT) , Sam’s Club (owned by Walmart) and Ingle’s Markets (IMKTA)  have the least to lose.

stock market indicators: EnLink Midstream Partners, LP(ENLK)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    EnLink Midstream Partners (ENLK) is sponsored by independent oil and gas exploration giant Devon Energy (DVN), the owner of this acreage.

    These basins offer superior economics and EnLink’s close relationship with Devon provides leveraged exposure to the upstream operator’s accelerating activity in these plays.

learn stock market

Investment company John Paulson buys Vistra Energy Corp, Altaba Inc, T-Mobile US Inc, VWR Corp, Horizon Pharma PLC, Xcerra Corp, New Relic Inc, Monsanto Co, Dova Pharmaceuticals Inc, C.R. Bard Inc, sells Extended Stay America Inc, Akorn Inc, Teva Pharmaceutical Industries, Mead Johnson Nutrition Co, The WhiteWave Foods Co during the 3-months ended 2017-06-30, according to the most recent filings of the investment company, Paulson & Co.. As of 2017-06-30, Paulson & Co. owns 108 stocks with a total value of $7.4 billion. These are the details of the buys and sells.

New Purchases: VST, AABA, VWR, HZNP, XCRA, NEWR, DOVA, BCR, TGNA, CTRP, Added Positions: TMUS, VRX, DISH, MON, MBBYF, TEAM, RAI, NXPI, FDX, ISRG, Reduced Positions: STAY, TEVA, SHPG, AGN, MYL, ALXN, MNK, AIG, RLGY, STE, Sold Out: AKRX, MJN, WWAV, EBAY, PFE, FGL, ETSY, NSR, BIIB, SRPT,

For the details of John Paulson’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=John+Paulson

These are the top 5 holdings of John PaulsonAllergan PLC (AGN) – 2,703,570 shares, 8.94% of the total portfolio. Shares reduced by 8.1%Mylan NV (MYL) – 15,933,600 shares, 8.41% of the total portfolio. Shares reduced by 7.76%Shire PLC (SHPG) – 3,481,600 shares, 7.83% of the total portfolio. Shares reduced by 12.92%SPDR Gold Trust (GLD) – 4,359,722 shares, 7% of the total portfolio. Valeant Pharmaceuticals International Inc (VRX) – 21,813,400 shares, 5.13% of the total portfolio. Shares added by 12.53%New Purchase: Vistra Energy Corp (VST)

John Paulson initiated holdings in Vistra Energy Corp. The purchase prices were between $14.59 and $16.86, with an estimated average price of $15.72. The stock is now traded at around $18.09. The impact to the portfolio due to this purchase was 2.63%. The holdings were 11,530,556 shares as of 2017-06-30.

learn stock market: EnLink Midstream Partners, LP(ENLK)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    EnLink Midstream Partners (ENLK) is sponsored by independent oil and gas exploration giant Devon Energy (DVN), the owner of this acreage.

    These basins offer superior economics and EnLink’s close relationship with Devon provides leveraged exposure to the upstream operator’s accelerating activity in these plays.

learn stock market: THERMOGENESIS Corp.(KOOL)

Advisors’ Opinion:

  • [By Lee Jackson]

    Cesca Therapeutics Inc. (NASDAQ: KOOL) had a 10% owner come in with a big-time purchase. Boyalfe bought a total of 6,102,942 shares of the stock a $2.52. The total for the purchase was posted at $6,838, 237.The company develops and manufactures automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products. Its stock traded on Friday’s close at $3.45, so a well-timed buy.The 52-week range is $1.60 to $7.39. The consensus price targetis $2.

learn stock market: Coca-Cola Company (The)(KO)

Advisors’ Opinion:

  • [By Chris Lange]

    The Coca-Cola Co. (NYSE: KO) will share its latest quarterly earnings on Wednesday. The consensus estimates call for $0.58 in EPS and $9.65 billion in revenue. Shares ended last week at $45.03, in a 52-week range of $39.88 to $46.06. The consensus price target is $45.68.

  • [By Ben Levisohn]

    We recently reached out to our retailer contacts to get an updated read on recent performance of Monster. Based on retailer feedback, we see a negative risk/reward for the stock ahead of Q4 results on 3/1 given: (1) soft scanner data, particularly in Dec & Jan as energy sales are definitely soft compared to other categories according to one retailer while another reported Monster started 2017 off horribly; (2) Java production issues persist; (3) poor retailer feedback on the rollout of Mutant continues in part based on the view that Coca-Cola (KO) is not executing on all cylinders and consumer reception of the product has not shown it to be anything great and certainly at this point is no threat to Mt. Dew; and (4) retailers modest outlook for Monster in 2017 (low- to mid-single digit growth on average).

  • [By Jon C. Ogg]

    Coca-Cola Co.(NYSE: KO) was the exact same stake of 400 million shares. This has been a position thatalso has remained static, and Buffett has defended his stake here for years.

  • [By Craig Jones]

    On CNBC's "Fast Money Halftime Report," Pete Najarian said that he noticed unusually high bullish options activity in The Coca-Cola Co (NYSE: KO).

  • [By Demitrios Kalogeropoulos]

    That’s why many investors shop among the short list ofDividend Aristocrats, which are companies that boast an unbroken streak of at least 25 years of consecutive payout raises. A few members of that elite group have fallen out of favor recently and could represent solid long-term buys. Below, we’ll look at the prospects for market-beating returns fromCoca-Cola(NYSE:KO),Target(NYSE:TGT), andLowe’s(NYSE:LOW).

  • [By Casey Wilson]

    Coca-Cola Co. (NYSE: KO) CEO Muhtar Kent snagged an outrageously high bonus last year, even though the beverage distributer reported less than stellar financials.

learn stock market: Xplore Technologies Corp(XPLR)

Advisors’ Opinion:

  • [By Monica Gerson]

     

    General Mills, Inc. (NYSE: GIS) is expected to report its quarterly earnings at $0.60 per share on revenue of $3.86 billion.
    Pier 1 Imports Inc (NYSE: PIR) is projected to post a quarterly loss at $0.05 per share on revenue of $420.05 million.
    Acuity Brands, Inc. (NYSE: AYI) is estimated to report its quarterly earnings at $2.03 per share on revenue of $847.79 million.
    Monsanto Company (NYSE: MON) is projected to report its quarterly earnings at $2.40 per share on revenue of $4.49 billion.
    Worthington Industries, Inc. (NYSE: WOR) is expected to report its quarterly earnings at $0.64 per share on revenue of $692.48 million.
    Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $94.64 million.
    UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.34 per share on revenue of $366.28 million.
    Exfo Inc (NASDAQ: EXFO) is expected to post its quarterly earnings at $0.06 per share on revenue of $60.87 million.
    OMNOVA Solutions Inc. (NYSE: OMN) is projected to report its quarterly earnings at $0.14 per share on revenue of $205.40 million.
    8Point3 Energy Partners LP (NASDAQ: CAFD) is estimated to post a quarterly loss at $0.01 per share on revenue of $11.60 million.
    Park Electrochemical Corp. (NYSE: PKE) is expected to report its quarterly earnings at $0.22 per share on revenue of $35.30 million.
    Xplore Technologies Corp. (NASDAQ: XPLR) is projected to post its quarterly earnings at $0.01 per share on revenue of $24.00 million.
    Investors Real Estate Trust (NYSE: IRET) is expected to post its quarterly earnings at $0.14 per share on revenue of $56.87 million.
    Tel-Instrument Electronics Corp. (NYSE: TIK) is estimated to post earnings for the latest quarter.
    Aethlon Medical, Inc. (NASDAQ: AEMD) is expected to post a quarterly loss at $0.20 per share.
    Ossen Innovation Co Ltd (ADR) (NASDAQ: OSN) is projected to post ea

learn stock market: WEX Inc.(WEX)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.